Invasive Skull Base Mucormycosis (eBook)
326 Seiten
Thieme Medical Publishers (Verlag)
978-93-95390-35-4 (ISBN)
1
Mucormycosis in Pre-COVID-19 Era
Chapter 1 | Mucormycosis in Pre-COVID-19 Era |
Sampath Chandra Prasad Rao, Ananth Chintapalli, and Sunena Saju |
Introduction
Zygomycetes class of fungi comprises of the order Mucorales and Entomophthorales. The Entomophthorales are rare cause of subcutaneous and new cutaneous infection known as entomophthoramycosis. The order Mucorales comprise of 55 genera with 261 species.
Not all 261 species cause human infection. Just a subset of this order, about 38 species, have been proved to cause infection in human being (Table 1.1).
Table 1.1 Current nomenclature of medically important mucoralean species according to updated taxonomy1
Current species names | Previous names/synonyms |
Lichtheimia corymbifera | Absidia corymbifera, Mycocladus corymbifer |
Lichtheimia ornata | Absidia ornata |
Lichtheimia ramosa | Absidia ramosa, Mycocladus ramosus |
Mucor ardhlaengiktus | Mucor ellipsoideus, Mucor circinelloides f. circinelloides |
Mucor circinelloides | Rhizomucor regularior, Rhizomucor variabilis var. regularior |
Mucor griseocyanus | Mucor circinelloides f. griseocyanus |
Mucor irregularis | Rhizomucor variabilis |
Mucor janssenii | Mucor circinelloides f. janssenii |
Mucor lusitanicus | Mucor circinelloides f. lusitanicus |
Rhizopus arrhizus (incl. var. delemar) | Rhizopus oryzae |
Rhizopus microsporus | Rhizopus microsporus var. azygosporus, var. chinensis, var. oligosporus, var. rhizopodiformis, var. tuberosus |
In 1876, Furbinger from Germany described fungal hyphae and few sporangia within hemorrhagic infarct in the lungs of a patient who died of cancer.2 This is considered the first ever documented case of mucormycosis. Arnold Paltauf in 1885 published the first case of disseminated mucormycosis coma which he named mycosis mucorina.3 In 1943, a case series of three fatal cases of advanced rhinocerebral mucormycosis in patients with diabetic ketoacidosis (DKA) were reported where typical findings like proptosis and ophthalmoplegia were described.4 It was only in 1955, after the development of amphotericin, the first cured case of mucormycosis was reported.5
Incidence of the disease went up from zero over the years and now is considered the third most common opportunistic fungal infection after candidiasis and aspergillosis.6 Increase in incidence of mucormycosis was documented well in literature but determination of exact incidence was a dilemma because population-based studies would vary in time period, population definition, and diagnostic parameters. Rising trend of mucormycosis in India is well documented in literature by various studies like by Chakrabarti et al. In their study, data from three consecutive studies from a single center reflected an incidence of 12.9 cases per year in the first decade, 35.6 cases per year over a period of 5 years, and 50 cases per year for 18 months.7–9 Similar rising trend was shown in a population-based study by Bitar et al in France between 1997 and 2006 and by Saegeman et al from Belgium in 2010.10,11 An alarming shift in mucormycosis cases from community acquired to nosocomial infection in susceptible host is also noted.12 Various studies like those by Mitchell et al and Verweij et al discuss the incidence of mucormycosis due to the use of contaminated wooden tongue depressor in preterm neonates and contaminated wooden applicator used to mix drugs in immunocompromised patients, respectively.13,14 A clear understanding of pathogenesis is important and inevitable in preventing and treating mucormycosis.
Pathogenesis
Pathogenesis of mucormycosis begins with inhalation or ingestion of sporangiospores, or inoculation of conidia via puncture wounds or trauma.15,16 The pathogenesis can be discussed under the following subheadings:
•Host defense mechanisms.
•Role of iron in pathogenesis.
•Fungal endothelial interactions.
Host Defense Mechanisms
Mucorales need to evade host defense mechanism, invade vascular system, and scavenge host immune system for growth and to cause disease.
In a normal healthy individual (host), primary defense mechanism against Mucorales includes:
•Specialized iron binding protein sequestering serum iron from organism.
•Endothelial cells which regulate vascular tone and permeability.
•Circulating mononuclear and polymorphonuclear (PMN) phagocytes which generate oxidative metabolites and cationic peptides (defensins).
•Neutrophils which on exposure to Mucorales upregulate expression of toll-like receptor 2 and rapidly induce NF-kB pathway related genes.17
Any condition resulting in imbalance of the above defense system can make an individual prone to mucormycosis like malignant hematological disease with or without stem cell transplantation, neutropenia, diabetes mellitus (DM) poorly controlled with or without DKA, iron overload, and major trauma.
Role of Iron in Pathogenesis
Iron plays a crucial role in the pathogenesis of mucormycosis. Mucorales have multiple pathways to acquire iron from the host. In the first mechanism, in patients with DKA or any state of systemic acidosis the available iron level in serum is high predisposing the individual to mucormycosis. This is because acidosis per se disrupts the capacity of transferrin to bind iron.
Second, an increased incidence of invasive mycosis is noted in patients with iron overload and patients on treatment with iron chelator deferoxamine. Fungi can obtain iron from the host with high affinity and permit low molecular weight iron chelator.18,19
Rhizopus species utilizes deferoxamine as a siderophore for acquiring iron from the host. A few species of Rhizopus can accumulate greater amounts of iron supplied by deferoxamine than Aspergillus fumigatus and Candida albicans.
There is a linear correlation between iron uptake by Rhizopus and its growth in serum.20 The latest iron chelators like deferiprone and deferasirox do not have siderophore activity. Fungi has high affinity iron permease which contain redundant surface reductases that reduce ferric into the soluble ferrous form. The protein complex comprising of a multicopper oxidase and ferrous permease captures the reduced ferrous iron.19
Rhizopus is also known to secrete rhizoferrin, a siderophore which supplies iron through an energy-dependent receptor-mediated process.21 Rhizoferrin lacks ability to take iron from serum, and the organism adapts to use of xenosiderophore like desferoxamine to obtain iron more efficiently. The third mechanism adopted by fungi to obtain iron is through the use of heme. The Rhizopus oryzae homologues of heme oxygenase enable it to obtain iron from lost hemoglobin which explains the angioinvasive nature of R. oryzae. High affinity iron permease gene (FTR1) in R. oryzae facilitates intracellular heme uptake by acting as cytoplasmic membrane permease, followed by heme oxygenase which degrade heme and release ferric iron. Sre A, a transcriptional regulator gene, and genes encoding for two ferritin orthologues for storage of iron, are other genes likely involved in the iron uptake mechanism of R. oryzae.22
Fungal Endothelial Interactions
R. oryzae strains adhere to type IV collagens and extracellular matrix laminin. Recently, GRP78 glucose regulated protein was identified to act as a receptor that mediates penetration through and damage of endothelial cells by Mucorales. GRP78 is also known as BiP/HSPAS member of HSP70 family in endoplasmic reticulum. It functions as a cellular chaperone protein, and recent studies report translocation of a fraction of GRP78 to cell surface.23
It is also interesting to find that along with elevated levels of glucose and iron, there is also enhanced expression of GRP78 surface protein which result in penetration through and damage of endothelial cells by Mucorales.
Other putative virulence factors are:
•Circulatory mononuclear and PMN lymphocytes are a major line of host defense which in presence of hyperglycemia and low pH is found to be dysfunctional.24 They have impaired chemotaxis and defective intracellular killing by both oxidative and nonoxidative24 mechanisms.
•In a study by Waldorf et al, they describe how critical it is for inhaled...
Erscheint lt. Verlag | 10.1.2024 |
---|---|
Zusatzinfo | Beilage: Videos |
Sprache | englisch |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► HNO-Heilkunde |
Medizinische Fachgebiete ► Innere Medizin ► Pneumologie | |
Schlagworte | Endoscopic sinus surgery • Maxillectomy • Orbital exenteration • Rhinectomy • Surgical debridement |
ISBN-10 | 93-95390-35-2 / 9395390352 |
ISBN-13 | 978-93-95390-35-4 / 9789395390354 |
Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
Haben Sie eine Frage zum Produkt? |
Größe: 79,9 MB
DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasserzeichen und ist damit für Sie personalisiert. Bei einer missbräuchlichen Weitergabe des eBooks an Dritte ist eine Rückverfolgung an die Quelle möglich.
Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belletristik und Sachbüchern. Der Fließtext wird dynamisch an die Display- und Schriftgröße angepasst. Auch für mobile Lesegeräte ist EPUB daher gut geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür die kostenlose Software Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür eine kostenlose App.
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich